Advertisement

Index by author

May 01, 1994; Volume 22,Issue 3

A

  1. Achkar, C C

    1. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
      C C Achkar, J M Bentel, J F Boylan, H I Scher, L J Gudas and W H Miller
      Drug Metabolism and Disposition May 1994, 22 (3) 451-458;

  2. Anders, M W

    1. Brain uptake and biotransformation of remacemide hydrochloride, a novel anticonvulsant.
      H Heyn, D J McCarthy, S H Curry, M S Eisman and M W Anders
      Drug Metabolism and Disposition May 1994, 22 (3) 443-446;

B

  1. Bailey, G S

    1. Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat.
      D M Stresser, G S Bailey and D E Williams
      Drug Metabolism and Disposition May 1994, 22 (3) 383-391;
    2. Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exo-epoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo.
      D M Stresser, D E Williams, L I McLellan, T M Harris and G S Bailey
      Drug Metabolism and Disposition May 1994, 22 (3) 392-399;

  2. Bednarski, P J

    1. Reversible and irreversible interactions of a cisplatin analog bearing a 1,2-diphenylethylenediamine ligand with plasma and plasma proteins in vitro.
      P J Bednarski, N A Kratochwil and A M Otto
      Drug Metabolism and Disposition May 1994, 22 (3) 419-427;

  3. Bentel, J M

    1. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
      C C Achkar, J M Bentel, J F Boylan, H I Scher, L J Gudas and W H Miller
      Drug Metabolism and Disposition May 1994, 22 (3) 451-458;

  4. Benvenuto, J A

    1. Preclinical pharmacology of the natural marine product dolastatin 10 (NSC 376128).
      R A Newman, A Fuentes, J M Covey and J A Benvenuto
      Drug Metabolism and Disposition May 1994, 22 (3) 428-432;

  5. Bindra, D S

    1. Urinary and biliary disposition of the lactone and carboxylate forms of 20(S)-camptothecin in rats.
      D O Scott, D S Bindra, S C Sutton and V J Stella
      Drug Metabolism and Disposition May 1994, 22 (3) 438-442;

  6. Boylan, J F

    1. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
      C C Achkar, J M Bentel, J F Boylan, H I Scher, L J Gudas and W H Miller
      Drug Metabolism and Disposition May 1994, 22 (3) 451-458;

  7. Brewer, C F

    1. Hepatic microsomal azoreductase activity. Reactivity of azo dye substrates is determined by their electron densities and redox potentials.
      S Zbaida, C F Brewer and W G Levine
      Drug Metabolism and Disposition May 1994, 22 (3) 412-418;

  8. Brewer, T G

    1. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
      M T Marino, J O Peggins, L D Brown, M R Urquhart and T G Brewer
      Drug Metabolism and Disposition May 1994, 22 (3) 358-366;

  9. Brown, L D

    1. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
      M T Marino, J O Peggins, L D Brown, M R Urquhart and T G Brewer
      Drug Metabolism and Disposition May 1994, 22 (3) 358-366;

C

  1. Chen, I W

    1. Nonlinear kinetics of alendronate. Plasma protein binding and bone uptake.
      J H Lin, I W Chen and F A deLuna
      Drug Metabolism and Disposition May 1994, 22 (3) 400-405;

  2. Chesa-Jiménez, J

    1. Studies on the renal excretion mechanisms of cefadroxil.
      L Granero, M J Gimeno, F Torres-Molina, J Chesa-Jiménez and J E Peris
      Drug Metabolism and Disposition May 1994, 22 (3) 447-450;

  3. Chow, H H

    1. Disposition kinetics of d- and l-amphetamine following intravenous administration of racemic amphetamine to rats.
      A Hutchaleelaha, J Sukbuntherng, H H Chow and M Mayersohn
      Drug Metabolism and Disposition May 1994, 22 (3) 406-411;

  4. Christensen, S B

    1. Metabolism of thapsigargin in rat hepatocytes.
      M S Nielsen, C E Olsen, J Dich, S B Christensen and N Grunnet
      Drug Metabolism and Disposition May 1994, 22 (3) 433-437;

  5. Clement, B

    1. N-hydroxylation of the antiprotozoal drug pentamidine catalyzed by rabbit liver cytochrome P-450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Possible relationship to the biological oxidation of arginine to NG-hydroxyarginine, citrulline, and nitric oxide.
      B Clement and F Jung
      Drug Metabolism and Disposition May 1994, 22 (3) 486-497;

  6. Covey, J M

    1. Preclinical pharmacology of the natural marine product dolastatin 10 (NSC 376128).
      R A Newman, A Fuentes, J M Covey and J A Benvenuto
      Drug Metabolism and Disposition May 1994, 22 (3) 428-432;

  7. Curry, S H

    1. Brain uptake and biotransformation of remacemide hydrochloride, a novel anticonvulsant.
      H Heyn, D J McCarthy, S H Curry, M S Eisman and M W Anders
      Drug Metabolism and Disposition May 1994, 22 (3) 443-446;

D

  1. deLuna, F A

    1. Nonlinear kinetics of alendronate. Plasma protein binding and bone uptake.
      J H Lin, I W Chen and F A deLuna
      Drug Metabolism and Disposition May 1994, 22 (3) 400-405;

  2. Dich, J

    1. Metabolism of thapsigargin in rat hepatocytes.
      M S Nielsen, C E Olsen, J Dich, S B Christensen and N Grunnet
      Drug Metabolism and Disposition May 1994, 22 (3) 433-437;

  3. Doll, M A

    1. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
      R J Ferguson, M A Doll, T D Rustan, K Gray and D W Hein
      Drug Metabolism and Disposition May 1994, 22 (3) 371-376;

E

  1. Eisman, M S

    1. Brain uptake and biotransformation of remacemide hydrochloride, a novel anticonvulsant.
      H Heyn, D J McCarthy, S H Curry, M S Eisman and M W Anders
      Drug Metabolism and Disposition May 1994, 22 (3) 443-446;

F

  1. Ferguson, R J

    1. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
      R J Ferguson, M A Doll, T D Rustan, K Gray and D W Hein
      Drug Metabolism and Disposition May 1994, 22 (3) 371-376;

  2. Fuentes, A

    1. Preclinical pharmacology of the natural marine product dolastatin 10 (NSC 376128).
      R A Newman, A Fuentes, J M Covey and J A Benvenuto
      Drug Metabolism and Disposition May 1994, 22 (3) 428-432;

  3. Fukuyama, T

    1. A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats.
      T Fukuyama, K Yamaoka, Y Ohata and T Nakagawa
      Drug Metabolism and Disposition May 1994, 22 (3) 479-485;

G

  1. George, M C

    1. In vitro metabolism of zatosetron. Interspecies comparison and role of CYP 3A.
      B J Ring, C J Parli, M C George and S A Wrighton
      Drug Metabolism and Disposition May 1994, 22 (3) 352-357;

  2. Gimeno, M J

    1. Studies on the renal excretion mechanisms of cefadroxil.
      L Granero, M J Gimeno, F Torres-Molina, J Chesa-Jiménez and J E Peris
      Drug Metabolism and Disposition May 1994, 22 (3) 447-450;

  3. Granero, L

    1. Studies on the renal excretion mechanisms of cefadroxil.
      L Granero, M J Gimeno, F Torres-Molina, J Chesa-Jiménez and J E Peris
      Drug Metabolism and Disposition May 1994, 22 (3) 447-450;

  4. Gray, K

    1. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
      R J Ferguson, M A Doll, T D Rustan, K Gray and D W Hein
      Drug Metabolism and Disposition May 1994, 22 (3) 371-376;

  5. Grunnet, N

    1. Metabolism of thapsigargin in rat hepatocytes.
      M S Nielsen, C E Olsen, J Dich, S B Christensen and N Grunnet
      Drug Metabolism and Disposition May 1994, 22 (3) 433-437;

  6. Gudas, L J

    1. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
      C C Achkar, J M Bentel, J F Boylan, H I Scher, L J Gudas and W H Miller
      Drug Metabolism and Disposition May 1994, 22 (3) 451-458;

H

  1. Hara, K

    1. Binding of dorzolamide and its metabolite, N-deethylated dorzolamide, to human erythrocytes in vitro.
      T Hasegawa, K Hara and S Hata
      Drug Metabolism and Disposition May 1994, 22 (3) 377-382;

  2. Harris, T M

    1. Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exo-epoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo.
      D M Stresser, D E Williams, L I McLellan, T M Harris and G S Bailey
      Drug Metabolism and Disposition May 1994, 22 (3) 392-399;

  3. Hasegawa, T

    1. Binding of dorzolamide and its metabolite, N-deethylated dorzolamide, to human erythrocytes in vitro.
      T Hasegawa, K Hara and S Hata
      Drug Metabolism and Disposition May 1994, 22 (3) 377-382;

  4. Hata, S

    1. Binding of dorzolamide and its metabolite, N-deethylated dorzolamide, to human erythrocytes in vitro.
      T Hasegawa, K Hara and S Hata
      Drug Metabolism and Disposition May 1994, 22 (3) 377-382;

  5. Hein, D W

    1. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
      R J Ferguson, M A Doll, T D Rustan, K Gray and D W Hein
      Drug Metabolism and Disposition May 1994, 22 (3) 371-376;

  6. Heyn, H

    1. Brain uptake and biotransformation of remacemide hydrochloride, a novel anticonvulsant.
      H Heyn, D J McCarthy, S H Curry, M S Eisman and M W Anders
      Drug Metabolism and Disposition May 1994, 22 (3) 443-446;

  7. Hollenberg, P F

    1. Inactivation of purified rat liver cytochrome P-450 2B1 and rabbit liver cytochrome P-450 2B4 by N-methylcarbazole.
      S C Kuemmerle, T Shen and P F Hollenberg
      Drug Metabolism and Disposition May 1994, 22 (3) 343-351;

  8. Hutchaleelaha, A

    1. Disposition kinetics of d- and l-amphetamine following intravenous administration of racemic amphetamine to rats.
      A Hutchaleelaha, J Sukbuntherng, H H Chow and M Mayersohn
      Drug Metabolism and Disposition May 1994, 22 (3) 406-411;

I

  1. Inaba, T

    1. Carbonyl reductase activity for acetohexamide in human erythrocytes.
      M Kishimoto, R Kawamori, T Kamada and T Inaba
      Drug Metabolism and Disposition May 1994, 22 (3) 367-370;

J

  1. Jung, F

    1. N-hydroxylation of the antiprotozoal drug pentamidine catalyzed by rabbit liver cytochrome P-450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Possible relationship to the biological oxidation of arginine to NG-hydroxyarginine, citrulline, and nitric oxide.
      B Clement and F Jung
      Drug Metabolism and Disposition May 1994, 22 (3) 486-497;

K

  1. Kamada, T

    1. Carbonyl reductase activity for acetohexamide in human erythrocytes.
      M Kishimoto, R Kawamori, T Kamada and T Inaba
      Drug Metabolism and Disposition May 1994, 22 (3) 367-370;

  2. Kawamori, R

    1. Carbonyl reductase activity for acetohexamide in human erythrocytes.
      M Kishimoto, R Kawamori, T Kamada and T Inaba
      Drug Metabolism and Disposition May 1994, 22 (3) 367-370;

  3. Kishimoto, M

    1. Carbonyl reductase activity for acetohexamide in human erythrocytes.
      M Kishimoto, R Kawamori, T Kamada and T Inaba
      Drug Metabolism and Disposition May 1994, 22 (3) 367-370;

  4. Kratochwil, N A

    1. Reversible and irreversible interactions of a cisplatin analog bearing a 1,2-diphenylethylenediamine ligand with plasma and plasma proteins in vitro.
      P J Bednarski, N A Kratochwil and A M Otto
      Drug Metabolism and Disposition May 1994, 22 (3) 419-427;

  5. Kuemmerle, S C

    1. Inactivation of purified rat liver cytochrome P-450 2B1 and rabbit liver cytochrome P-450 2B4 by N-methylcarbazole.
      S C Kuemmerle, T Shen and P F Hollenberg
      Drug Metabolism and Disposition May 1994, 22 (3) 343-351;

L

  1. Levine, B S

    1. Cocaine pharmacokinetics in ethanol-pretreated rats.
      B S Levine and I R Tebbett
      Drug Metabolism and Disposition May 1994, 22 (3) 498-500;

  2. Levine, W G

    1. Hepatic microsomal azoreductase activity. Reactivity of azo dye substrates is determined by their electron densities and redox potentials.
      S Zbaida, C F Brewer and W G Levine
      Drug Metabolism and Disposition May 1994, 22 (3) 412-418;

  3. Lin, J H

    1. Nonlinear kinetics of alendronate. Plasma protein binding and bone uptake.
      J H Lin, I W Chen and F A deLuna
      Drug Metabolism and Disposition May 1994, 22 (3) 400-405;

M

  1. Marino, M T

    1. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
      M T Marino, J O Peggins, L D Brown, M R Urquhart and T G Brewer
      Drug Metabolism and Disposition May 1994, 22 (3) 358-366;

  2. Mayersohn, M

    1. Disposition kinetics of d- and l-amphetamine following intravenous administration of racemic amphetamine to rats.
      A Hutchaleelaha, J Sukbuntherng, H H Chow and M Mayersohn
      Drug Metabolism and Disposition May 1994, 22 (3) 406-411;

  3. McCarthy, D J

    1. Brain uptake and biotransformation of remacemide hydrochloride, a novel anticonvulsant.
      H Heyn, D J McCarthy, S H Curry, M S Eisman and M W Anders
      Drug Metabolism and Disposition May 1994, 22 (3) 443-446;

  4. McLellan, L I

    1. Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exo-epoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo.
      D M Stresser, D E Williams, L I McLellan, T M Harris and G S Bailey
      Drug Metabolism and Disposition May 1994, 22 (3) 392-399;

  5. Miller, W H

    1. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
      C C Achkar, J M Bentel, J F Boylan, H I Scher, L J Gudas and W H Miller
      Drug Metabolism and Disposition May 1994, 22 (3) 451-458;

  6. Monro, A M

    1. Are routine tissue distribution studies justifiable for approval of human drugs?
      A M Monro
      Drug Metabolism and Disposition May 1994, 22 (3) 341-342;

N

  1. Nakagawa, T

    1. A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats.
      T Fukuyama, K Yamaoka, Y Ohata and T Nakagawa
      Drug Metabolism and Disposition May 1994, 22 (3) 479-485;

  2. Newman, R A

    1. Preclinical pharmacology of the natural marine product dolastatin 10 (NSC 376128).
      R A Newman, A Fuentes, J M Covey and J A Benvenuto
      Drug Metabolism and Disposition May 1994, 22 (3) 428-432;

  3. Nielsen, M S

    1. Metabolism of thapsigargin in rat hepatocytes.
      M S Nielsen, C E Olsen, J Dich, S B Christensen and N Grunnet
      Drug Metabolism and Disposition May 1994, 22 (3) 433-437;

O

  1. Ohata, Y

    1. A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats.
      T Fukuyama, K Yamaoka, Y Ohata and T Nakagawa
      Drug Metabolism and Disposition May 1994, 22 (3) 479-485;

  2. Olsen, C E

    1. Metabolism of thapsigargin in rat hepatocytes.
      M S Nielsen, C E Olsen, J Dich, S B Christensen and N Grunnet
      Drug Metabolism and Disposition May 1994, 22 (3) 433-437;

  3. Otto, A M

    1. Reversible and irreversible interactions of a cisplatin analog bearing a 1,2-diphenylethylenediamine ligand with plasma and plasma proteins in vitro.
      P J Bednarski, N A Kratochwil and A M Otto
      Drug Metabolism and Disposition May 1994, 22 (3) 419-427;

P

  1. Parli, C J

    1. In vitro metabolism of zatosetron. Interspecies comparison and role of CYP 3A.
      B J Ring, C J Parli, M C George and S A Wrighton
      Drug Metabolism and Disposition May 1994, 22 (3) 352-357;

  2. Peggins, J O

    1. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
      M T Marino, J O Peggins, L D Brown, M R Urquhart and T G Brewer
      Drug Metabolism and Disposition May 1994, 22 (3) 358-366;

  3. Peris, J E

    1. Studies on the renal excretion mechanisms of cefadroxil.
      L Granero, M J Gimeno, F Torres-Molina, J Chesa-Jiménez and J E Peris
      Drug Metabolism and Disposition May 1994, 22 (3) 447-450;

Q

  1. Qiao, G L

    1. Percutaneous absorption, biotransformation, and systemic disposition of parathion in vivo in swine. I. Comprehensive pharmacokinetic model.
      G L Qiao, P L Williams and J E Riviere
      Drug Metabolism and Disposition May 1994, 22 (3) 459-471;

R

  1. Ring, B J

    1. In vitro metabolism of zatosetron. Interspecies comparison and role of CYP 3A.
      B J Ring, C J Parli, M C George and S A Wrighton
      Drug Metabolism and Disposition May 1994, 22 (3) 352-357;

  2. Riviere, J E

    1. Percutaneous absorption, biotransformation, and systemic disposition of parathion in vivo in swine. I. Comprehensive pharmacokinetic model.
      G L Qiao, P L Williams and J E Riviere
      Drug Metabolism and Disposition May 1994, 22 (3) 459-471;

  3. Rustan, T D

    1. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
      R J Ferguson, M A Doll, T D Rustan, K Gray and D W Hein
      Drug Metabolism and Disposition May 1994, 22 (3) 371-376;

S

  1. Scher, H I

    1. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
      C C Achkar, J M Bentel, J F Boylan, H I Scher, L J Gudas and W H Miller
      Drug Metabolism and Disposition May 1994, 22 (3) 451-458;

  2. Scott, D O

    1. Urinary and biliary disposition of the lactone and carboxylate forms of 20(S)-camptothecin in rats.
      D O Scott, D S Bindra, S C Sutton and V J Stella
      Drug Metabolism and Disposition May 1994, 22 (3) 438-442;

  3. Shen, T

    1. Inactivation of purified rat liver cytochrome P-450 2B1 and rabbit liver cytochrome P-450 2B4 by N-methylcarbazole.
      S C Kuemmerle, T Shen and P F Hollenberg
      Drug Metabolism and Disposition May 1994, 22 (3) 343-351;

  4. Stella, V J

    1. Urinary and biliary disposition of the lactone and carboxylate forms of 20(S)-camptothecin in rats.
      D O Scott, D S Bindra, S C Sutton and V J Stella
      Drug Metabolism and Disposition May 1994, 22 (3) 438-442;

  5. Stresser, D M

    1. Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat.
      D M Stresser, G S Bailey and D E Williams
      Drug Metabolism and Disposition May 1994, 22 (3) 383-391;
    2. Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exo-epoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo.
      D M Stresser, D E Williams, L I McLellan, T M Harris and G S Bailey
      Drug Metabolism and Disposition May 1994, 22 (3) 392-399;

  6. Sukbuntherng, J

    1. Disposition kinetics of d- and l-amphetamine following intravenous administration of racemic amphetamine to rats.
      A Hutchaleelaha, J Sukbuntherng, H H Chow and M Mayersohn
      Drug Metabolism and Disposition May 1994, 22 (3) 406-411;

  7. Sultatos, L G

    1. Kinetic mechanism of the detoxification of the organophosphate paraoxon by human serum A-esterase.
      J A Vitarius and L G Sultatos
      Drug Metabolism and Disposition May 1994, 22 (3) 472-478;

  8. Sutton, S C

    1. Urinary and biliary disposition of the lactone and carboxylate forms of 20(S)-camptothecin in rats.
      D O Scott, D S Bindra, S C Sutton and V J Stella
      Drug Metabolism and Disposition May 1994, 22 (3) 438-442;

T

  1. Tebbett, I R

    1. Cocaine pharmacokinetics in ethanol-pretreated rats.
      B S Levine and I R Tebbett
      Drug Metabolism and Disposition May 1994, 22 (3) 498-500;

  2. Torres-Molina, F

    1. Studies on the renal excretion mechanisms of cefadroxil.
      L Granero, M J Gimeno, F Torres-Molina, J Chesa-Jiménez and J E Peris
      Drug Metabolism and Disposition May 1994, 22 (3) 447-450;

U

  1. Urquhart, M R

    1. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
      M T Marino, J O Peggins, L D Brown, M R Urquhart and T G Brewer
      Drug Metabolism and Disposition May 1994, 22 (3) 358-366;

V

  1. Vitarius, J A

    1. Kinetic mechanism of the detoxification of the organophosphate paraoxon by human serum A-esterase.
      J A Vitarius and L G Sultatos
      Drug Metabolism and Disposition May 1994, 22 (3) 472-478;

W

  1. Williams, D E

    1. Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat.
      D M Stresser, G S Bailey and D E Williams
      Drug Metabolism and Disposition May 1994, 22 (3) 383-391;
    2. Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exo-epoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo.
      D M Stresser, D E Williams, L I McLellan, T M Harris and G S Bailey
      Drug Metabolism and Disposition May 1994, 22 (3) 392-399;

  2. Williams, P L

    1. Percutaneous absorption, biotransformation, and systemic disposition of parathion in vivo in swine. I. Comprehensive pharmacokinetic model.
      G L Qiao, P L Williams and J E Riviere
      Drug Metabolism and Disposition May 1994, 22 (3) 459-471;

  3. Wrighton, S A

    1. In vitro metabolism of zatosetron. Interspecies comparison and role of CYP 3A.
      B J Ring, C J Parli, M C George and S A Wrighton
      Drug Metabolism and Disposition May 1994, 22 (3) 352-357;

Y

  1. Yamaoka, K

    1. A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats.
      T Fukuyama, K Yamaoka, Y Ohata and T Nakagawa
      Drug Metabolism and Disposition May 1994, 22 (3) 479-485;

Z

  1. Zbaida, S

    1. Hepatic microsomal azoreductase activity. Reactivity of azo dye substrates is determined by their electron densities and redox potentials.
      S Zbaida, C F Brewer and W G Levine
      Drug Metabolism and Disposition May 1994, 22 (3) 412-418;
Back to top

In this issue

Advertisement